MarketPeel
Insider Trading Intelligence
TH

Tomohiro Higa

TNYA
SVP, FINANCE · TENAYA THERAPEUTICS, INC. · CIK 0002054280
FILING MIX · LIFETIME14%/86%
BUYS
2
SELLS
12
TOTAL VALUE
$10.9K
COMPANIES
1
ACTIVE SINCE
Mar 2025
HOLDINGS NOW
118,267
AVG SELL PX
$0.83
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 21 pending
Forward-return performance of every backtestable P/S trade by Tomohiro Higa, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+72.73%+6.45%+0.28%+6.17%-3.67%
14d11+54.55%+3.41%+0.64%+2.77%-12.47%
30d11+63.64%+2.90%-0.54%+3.44%-5.64%
60d11+36.36%+14.50%+3.03%+11.46%+19.93%
90d11+9.09%+25.13%+6.31%+18.82%+27.11%
180d11(3 pending)+50.00%+72.04%+11.48%+60.56%+58.03%
1y11(7 pending)+0.00%+86.27%+22.10%+64.17%+55.71%
2y11(11 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TNYA · 118,267 shares · as of May 18, 2026
043,87587,750131,625175,5002026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 2 buys / 12 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
1,485$0.79$1.2K118,267May 18, 2026May 19, 2026View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
836$0.64$538121,774Feb 17, 2026Feb 17, 2026View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
611$0.64$393122,610Feb 17, 2026Feb 17, 2026View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
2,022$0.64$1.3K119,752Feb 17, 2026Feb 17, 2026View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
175,500175,500Feb 3, 2026Feb 5, 2026View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
29,250123,221Feb 3, 2026Feb 5, 2026View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
1,367$1.33$1.8K93,971Nov 17, 2025Nov 17, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
1,722$1.25$2.2K95,338Aug 18, 2025Aug 18, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
717$1.25$89897,060Aug 18, 2025Aug 18, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
523$1.25$65597,777Aug 18, 2025Aug 18, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
1,390$0.44$61598,300May 16, 2025May 16, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
845$0.54$45599,690Mar 10, 2025Mar 10, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
1,017$0.54$548101,155Mar 10, 2025Mar 10, 2025View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
SVP, Finance
620$0.54$334100,535Mar 10, 2025Mar 10, 2025View →
Other insiders · TNYA
Loading peer insiders…
About this filer
CIK 0002054280
ROLE
SVP, Finance
PRIMARY
TNYA
COMPANIES
1
ACTIVE SINCE
Mar 2025
MARKETPEEL · /INSIDER/0002054280DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback